News for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Pennsylvania-based Longevity Health Holdings, Inc. (XAGE) is up over 93 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Pennsylvania-based Longevity Health Holdings, Inc. (XAGE) is up over 93 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday. The Dow traded up 0.05% to 44,393.18 while the NASDA...

Sonnet Biotherapeutics Holdings Inc. (SONN) has resumed trading, marking a significant development for the company. Investors who have been closely monitoring t

Trading for Sonnet Biotherapeutics Holdings Inc. (SONN) was temporarily suspended due to a volatility trading pause. This halt is a standard procedure to addres

Sonnet BioTherapeutics (SONN) stock surged 153% to $13.08 after announcing a $888 million business combination with Rorschach I LLC, forming Hyperliquid Strategies Inc. (HSI), which will hold 12.6 million HYPE tokens valued at $583 million and $305 million in cash. HSI, set to list on Nasdaq under a new ticker,…

U.S. stocks traded slightly lower this morning, with the Dow Jones index falling around 0.1% on Monday. Following the market opening Monday, the Dow traded dow...

Key Highlights: Sonnet BioTherapeutics to merge with Rorschach I LLC in a transformative $88 million deal. The merged company, Hyperliquid Strategies Inc

Sonnet BioTherapeutics (SONN) has revealed a strategic move to merge with Rorschach I LLC, an entity linked with Atlas Merchant Capital LLC and Paradigm Operati

Shares of Apogee Therapeutics, Inc. APGE rose sharply in today's pre-market trading after the company disclosed positive 16-week data from Phase 2 APEX clinical...

U.S. stock futures declined Monday morning as investors digested news that President Donald Trump has pushed back the implementation of previously announced

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Thursday. Following the market opening Thursday, the Dow trade...

South Korea-based Global Interactive Technologies, Inc. (GITS) is up over 146 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Shares of Datadog Inc DDOG rose sharply in pre-market trading followed the company's announcement of its inclusion in the S&P 500 index. S&P Dow Jones announce...

Shares of Box, Inc. BOX rose sharply in today's pre-market trading after the company posted better-than-expected first-quarter results and raised its FY2026 gui...

PRINCETON, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (SONN) (the "Company" or "Sonnet"), a clinical-stage company developin

\n Sonnet BioTherapeutics (SONN) reports positive safety results for SON-1010 combined with atezolizumab. The results are from a Phase 1b/2a clinical trial

**media[596956]**

Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq®) The maximum tolerated dose (